Activation of plasma procarboxypeptidase U in different mammalian species points to a conserved pathway of inhibition of fibrinolysisSCHATTEMAN, K. A; GOOSSENS, F. J; SCHARPE, S. S et al.Thrombosis and haemostasis. 1999, Vol 82, Num 6, pp 1718-1721, issn 0340-6245Article

Laser Scanning-Based Tissue Autofluorescence/ Fluorescence Imaging (LS-TAFI), a New Technique for Analysis of Microanatomy in Whole-Mount TissuesMORI, Hidetoshi; BOROWSKY, Alexander D; BHAT, Ramray et al.The American journal of pathology. 2012, Vol 180, Num 6, pp 2249-2256, issn 0002-9440, 8 p.Article

A novel inhibitor of activated thrombin-activatable fibrinolysis inhibitor (TAFIa) -Part I: Pharmacological characterizationWANG, Yi-Xin; LEI ZHAO; HRVATIN, Paul et al.Thrombosis and haemostasis. 2007, Vol 97, Num 1, pp 45-53, issn 0340-6245, 9 p.Article

New insights into factors affecting clot stability: A role for thrombin activatable fibrinolysis inhibitor (TAFI; plasma procarboxypeptidase B, plasma procarboxypeptidase U, procarboxypeptidase R)BOUMA, Bonno N; MEIJERS, Joost C. M.Seminars in hematology. 2004, Vol 41, Num 1, pp 13-19, issn 0037-1963, 7 p., SUP1Conference Paper

Elastase from activated human neutrophils activates procarboxypeptidase RKAWAMURA, Takeshi; OKADA, Noriko; OKADA, Hidechika et al.Microbiology and immunology. 2002, Vol 46, Num 3, pp 225-230, issn 0385-5600Article

Does thrombin Activatable Fibrinolysis Inhibitor (TAFI) contribute to impairment of Fibrinolysis in patients with preeclampsia and/or intrauterine fetal growth retardation?ANTOVIC, J. P; HAMAD, R. Rafik; ANTOVIC, A et al.Thrombosis and haemostasis. 2002, Vol 88, Num 4, pp 644-647, issn 0340-6245, 4 p.Article

Crystal structures of TAFI elucidate the inactivation mechanism of activated TAFI : a novel mechanism for enzyme autoregulation. CommentaryZONGCHAO JIA; MARX, Pauline F; BRONDIJK, T. Harma C et al.Blood. 2008, Vol 112, Num 7, issn 0006-4971, 2597-2598, 2803-2809 [9 p.]Article

Thrombin activatable fibrinolysis inhibitor (TAFI) in human amniotic fluid. A preliminary studyUSZYNSKI, Waldemar; USZYNSKI, Mieczysław; ZEKANOWSKA, Ewa et al.Thrombosis research. 2007, Vol 119, Num 2, pp 241-245, issn 0049-3848, 5 p.Article

Postprandial thrombin activatable fibrinolysis inhibitor and markers of endothelial dysfunction in type 2 diabetic patientsRIGLA, Mercedes; WÄGNER, Ana Maria; BORRELL, Montserrat et al.Metabolism, clinical and experimental. 2006, Vol 55, Num 11, pp 1437-1442, issn 0026-0495, 6 p.Article

Thrombin activatable fibrinolysis inhibitor (TAFI)- : How does thrombin regulate fibrinolysis?BOUMA, Bonno N; MOSNIER, Laurent O.Annals of medicine (Helsinki). 2006, Vol 38, Num 6, pp 378-388, issn 0785-3890, 11 p.Article

Development of ELISAs measuring the extent of TAFI activationCERESA, Erik; BROUWERS, Els; PEETERS, Miet et al.Arteriosclerosis, thrombosis, and vascular biology. 2006, Vol 26, Num 2, pp 423-428, issn 1079-5642, 6 p.Article

Measurement of procarboxypeptidase U (TAFI) in human plasma : A laboratory challengeWILLEMSE, Johan L; HENDRIKS, Dirk F.Clinical chemistry (Baltimore, Md.). 2006, Vol 52, Num 1, pp 30-36, issn 0009-9147, 7 p.Article

Changes in activity of plasma thrombin activatable fibrinolysis inhibitor in pregnancyWATANABE, Takashi; MINAKAMI, Hisanori; SAKATA, Yoichi et al.Gynecologic and obstetric investigation. 2004, Vol 58, Num 1, pp 19-21, issn 0378-7346, 3 p.Article

The role of protein S in the activation of thrombin activatable fibrinolysis inhibitor (TAFI) and regulation of fibrinolysisMOSNIER, Laurent O; MEIJERS, Joost C. M; BOUMA, Bonno N et al.Thrombosis and haemostasis. 2001, Vol 86, Num 4, pp 1040-1046, issn 0340-6245Article

Fast homogeneous assay for plasma procarboxypeptidase USCHATTEMAN, Katinka A; GOOSSENS, Filip J; LEURS, Judith et al.Clinical chemistry and laboratory medicine. 2001, Vol 39, Num 9, pp 806-810, issn 1434-6621Conference Paper

Regulation of fibrinolysis by thrombin activatable fibrinolysis inhibitor, An unstable carboxypeptidase B that unites the pathways of coagulation and fibrinolysisMOSNIER, Laurent O; BOUMA, Bonno N.Arteriosclerosis, thrombosis, and vascular biology. 2006, Vol 26, Num 11, pp 2445-2453, issn 1079-5642, 9 p.Article

Demonstration of enhanced endogenous fibrinolysis in thrombin activatable fibrinolysis inhibitor-deficient miceMAO, Shi-Shan; HOLAHAN, Marie A; BAILEY, Carolyn et al.Blood coagulation & fibrinolysis. 2005, Vol 16, Num 6, pp 407-415, issn 0957-5235, 9 p.Article

Association between thrombin activatable fibrinolysis inhibitor genotype and levels in plasma: comparison of different assaysGUIMARAES, A. H. C; VAN TILBURG, N. H; VOS, H. L et al.British journal of haematology. 2004, Vol 124, Num 5, pp 659-665, issn 0007-1048, 7 p.Article

Characterization of mouse thrombin-activatable fibrinolysis inhibitorMARX, P. F; WAGENAAR, G. T. M; REIJERKERK, A et al.Thrombosis and haemostasis. 2000, Vol 83, Num 2, pp 297-303, issn 0340-6245Article

Thrombin activatable fibrinolysis inhibitor and its fibrinolytic effect in normal pregnancyMOUSA, Hatem A; DOWNEY, Colin; ALFIREVIC, Zarko et al.Thrombosis and haemostasis. 2004, Vol 92, Num 5, pp 1025-1031, issn 0340-6245, 7 p.Article

Thrombin activatable fibrinolysis inhibitor (TAFI) levels in patients with coronary artery disease investigated by angiographySCHROEDER, Verena; CHATTERJEE, Tushar; MEHTA, Haresh et al.Thrombosis and haemostasis. 2002, Vol 88, Num 6, pp 1020-1025, issn 0340-6245, 6 p.Article

Patients on peritoneal dialysis but not on hemodialysis have elevated concentration and activity of thrombin-activatable fibrinolysis inhibitorHRYSZKO, Tomasz; MAŁYSZKO, Jolanta; MAŁYSZKO, Jacek S et al.Thrombosis research. 2001, Vol 104, Num 4, pp 233-238, issn 0049-3848Article

Serum thrombin activatable fibrinolysis inhibitor levels in patients with newly diagnosed multiple myelomaBALCIK, Ozlem S; ALBAYRAK, Murat; UYAR, Mehtap E et al.Blood coagulation & fibrinolysis. 2011, Vol 22, Num 4, pp 260-263, issn 0957-5235, 4 p.Article

Genetic and environmental influences on the fibrinolytic system: a twin studyPEETZ, Dirk; VICTOR, Anja; ADAMS, Petra et al.Thrombosis and haemostasis. 2004, Vol 92, Num 2, pp 344-351, issn 0340-6245, 8 p.Article

Thrombin activatable fibrinolysis inhibitor (TAFI) affects fibrinolysis in a plasminogen activator concentration-dependent manner: Study of seven plasminogen activators in an internal clot lysis modelGUIMARAES, Ana H. C; RIJKEN, Dingeman C.Thrombosis and haemostasis. 2004, Vol 91, Num 3, pp 473-479, issn 0340-6245, 7 p.Conference Paper